Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Horsmans, Yves" or (type any "bookEditor journalEditor issueEditor" and editor="Horsmans,...

Add to list
- Journal Article
- A1
- open access
Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

Sylvie Goletti, Siméon Zuyten, Léonie Goeminne, Chris Verhofstede (UGent) , Hector Rodriguez-Villalobos, Monique Bodeus, Peter Stärkel, Yves Horsmans and Benoît Kabamba-Mukadi

(2019) BMC INFECTIOUS DISEASES. 19(1).
Add to list
Pharmacokinetic interactions between simeprevir and ledipasvir in treatment naive hepatitis C virus genotype 1-Infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen

Stefan Bourgeois, Yves Horsmans, Frederik Nevens, Hans Van Vlierberghe (UGent) , Christophe Moreno, Maria Beumont, Leen Vijgen, Veerle van Eygen, Donghan Luo, Vera Hillewaert, et al.

(2017) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 61(12).
Add to list
- Journal Article
- A1
- open access
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Stefan Bourgeois, Hans Van Vlierberghe (UGent) , Christophe Moreno, Hans Orlent, Frederik Nevens, Keikawus Arastéh, Yves Horsmans, Jörn M Schattenberg, Peter Buggisch, Sven Francque, et al.

(2017) BMC GASTROENTEROLOGY. 17.
Add to list
- Journal Article
- A1
- open access
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial

Geert Leroux-Roels (UGent) , Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G Kremsner, Edwige Haelterman, Frédéric Clement (UGent) , et al.

(2016) CLINICAL IMMUNOLOGY. 169. p.16-27
Add to list
- Journal Article
- A1
- open access
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients : results from the GUARD-C cohort

Graham R. Foster, Carmine Coppola, Moutaz Derbala, Peter Ferenci, Alessandra Orlandini, K. Rajender Reddy, Ludovico Tallarico, Mitchell L. Shiffman, Silke Ahlers, Georgios Bakalos, et al.

(2016) PLOS ONE. 11(3).
Add to list
- Journal Article
- A1
- open access
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

Geert Leroux-Roels (UGent) , Pascale Van Belle, Pierre Vandepapeliere, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff and Marcelle Van Mechelen

(2015) VACCINE. 33(8). p.1084-1091
Add to list
Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials

Isabel Leroux-Roels (UGent) , Jeanne-Marie Devaster, Geert Leroux-Roels (UGent) , Vincent Verlant, Isabelle Henckaerts, Philippe Moris, Philippe Hermand, Pascale Van Belle, Jan T Poolman, Pierre Vandepapeliére, et al.

(2015) VACCINE. 33(4). p.577-584
Add to list
- Journal Article
- A1
- open access
Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Meng Fang (UGent) , Sylviane Dewaele (UGent) , Yun-peng Zhao, Peter Starkel, Valerie Vanhooren (UGent) , Yue-ming Chen, Xin Ji, Ming Luo, Bao-mu Sun, Yves Horsmans, et al.

(2010) MOLECULAR CANCER. 9.
Add to list
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Pierre Vandepapeliere, Yves Horsmans, Philippe Moris, Marcelle Van Mechelen, Michel Janssens, Marguerite Koutsoukos, Pascale Van Belle, Frédéric Clement (UGent) , Emmanuel Hanon, Martine Wettendorff, et al.

(2008) VACCINE. 26(10). p.1375-1386
Add to list
Oral fluid as a medium for the detection of hepatitis B surface antigen

Veronik Hutse, Els Verhaegen, Liesbet De Cock, Sophie Quoilin, Hans Vandenberghe, Yves Horsmans, Peter Michielsen, Pierre Van Damme, Hans Van Vlierberghe (UGent) , Françoise Claeys, et al.

(2005) JOURNAL OF MEDICAL VIROLOGY. 77(1). p.53-56

Academic Bibliography

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

Pharmacokinetic interactions between simeprevir and ledipasvir in treatment naive hepatitis C virus genotype 1-Infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients : results from the GUARD-C cohort

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials

Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Oral fluid as a medium for the detection of hepatitis B surface antigen

Contents

Support

Contact